Table 3 IMRT studies in larynx tumors
Patients (n) | Tumor stage | Chemotherapy | LRC | OS | |
|---|---|---|---|---|---|
Eisbruch[30] | 11 | n.a. | n. a. | 60% (3 yrs) | n. a. |
Yao[29] | 33 | n.a. | n. a. | 85% (2 yrs) | n. a. |
Lee[31] | 20 | III/IV: 100% | 100% | 90% (2 yrs) | 69% (2 yrs) |
Studer[28]* | 58 | I/II: 31% | 85% | 65% (3 yrs) | 78% (3 yrs) |
II/IVA: 69% | |||||
Nguyen[32] | 8 | III/IVA: 100% | 100% | 85.2% (2 yrs) | n. a. |
Current study | 77 | I/II: 54% | 28% | 76% (3 yrs) | 81% (3 yrs) |
II/IVA: 46% | 79% |